- Home
- HLF vs QURE Comparison
HLF vs QURE Comparison
Compare HLF & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLF
- QURE
- Stock Information
- Founded
- HLF 1980
- QURE 1998
- Country
- HLF United States
- QURE Netherlands
- Employees
- HLF N/A
- QURE N/A
- Industry
- HLF Other Pharmaceuticals
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- HLF Health Care
- QURE Health Care
- Exchange
- HLF Nasdaq
- QURE Nasdaq
- Market Cap
- HLF 583.2M
- QURE 691.2M
- IPO Year
- HLF N/A
- QURE 2007
- Fundamental
- Price
- HLF $8.33
- QURE $12.84
- Analyst Decision
- HLF Buy
- QURE Strong Buy
- Analyst Count
- HLF 5
- QURE 8
- Target Price
- HLF $9.90
- QURE $39.43
- AVG Volume (30 Days)
- HLF 3.7M
- QURE 820.4K
- Earning Date
- HLF 02-19-2025
- QURE 03-03-2025
- Dividend Yield
- HLF N/A
- QURE N/A
- EPS Growth
- HLF 76.06
- QURE N/A
- EPS
- HLF 2.50
- QURE N/A
- Revenue
- HLF $4,993,100,000.00
- QURE $28,587,000.00
- Revenue This Year
- HLF N/A
- QURE $153.92
- Revenue Next Year
- HLF $1.57
- QURE N/A
- P/E Ratio
- HLF $3.32
- QURE N/A
- Revenue Growth
- HLF N/A
- QURE N/A
- 52 Week Low
- HLF $5.04
- QURE $3.73
- 52 Week High
- HLF $12.79
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- HLF 77.90
- QURE 38.20
- Support Level
- HLF $5.57
- QURE $12.72
- Resistance Level
- HLF $8.40
- QURE $14.42
- Average True Range (ATR)
- HLF 0.39
- QURE 0.85
- MACD
- HLF 0.34
- QURE -0.26
- Stochastic Oscillator
- HLF 97.77
- QURE 7.26
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management; targeted nutrition; Energy, Sports, and Fitness; Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Mexico, South and Central America, EMEA, Asia-Pacific, and China.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.